Sales decline 5.67% to Rs 778.59 crore
Net loss of Glaxosmithkline Pharmaceuticals reported to Rs 661.16 crore in the quarter ended December 2019 as against net profit of Rs 113.67 crore during the previous quarter ended December 2018. Sales declined 5.67% to Rs 778.59 crore in the quarter ended December 2019 as against Rs 825.35 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales778.59825.35 -6 OPM %15.9816.62 -PBDT137.91153.68 -10 PBT119.58141.64 -16 NP-661.16113.67 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
